Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium – PubMed
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
At a recent Oncologic Drugs Advisory Committee (ODAC) Meeting, the U.S. Food and Drug Administration (FDA) laid out its rationale for rejecting the supplem
This is the recording of a lecture delivered to the National Breast Cancer Coalition (NBCC), a patient advocacy group focused on empowering patients with bre…
View this file, and add comments too.
Purpose In early-stage non-small cell lung cancer (NSCLC), post-treatment mortality may influence the comparative effectiveness of surgery and stereotactic body radiotherapy (SBRT), with implications for…
This study examines the potential benefits of aspirin as adjuvant therapy for survivors of early breast cancer.
Nature – Browser plug-in alerts users when studies — or their references — have been posted on a site known for raising integrity concerns.
Proposed Assisted Dying Bill: implications for mental healthcare and psychiatrists – Volume 221 Issue 1
Sip water throughout the day. Using a humidifier once or twice a day, especially in your sleeping area at night, can help a lot. Cool…
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.